Sanofi Stock price

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris 11:37:04 2024-02-09 am EST 5-day change 1st Jan Change
86.5 EUR +0.83% Intraday chart for Sanofi -1.22% -3.63%
Sales 2023 43.07B 46.43B Sales 2024 * 45.74B 49.31B Capitalization 108B 117B
Net income 2023 5.4B 5.82B Net income 2024 * 7.76B 8.37B EV / Sales 2023 2.79 x
Net Debt 2023 7.79B 8.4B Net Debt 2024 * 2.09B 2.25B EV / Sales 2024 * 2.42 x
P/E ratio 2023
20.8 x
P/E ratio 2024 *
14.6 x
Employees 91,573
Yield 2023
4.19%
Yield 2024 *
4.4%
Free-Float 87.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.83%
1 week-1.22%
Current month-7.35%
1 month-9.13%
3 months+0.49%
6 months-10.45%
Current year-3.63%
More quotes
1 week
85.51
Extreme 85.51
88.16
1 month
85.51
Extreme 85.51
96.50
Current year
85.51
Extreme 85.51
96.50
1 year
80.60
Extreme 80.6
105.18
3 years
74.92
Extreme 74.92
106.66
5 years
67.65
Extreme 67.65
106.66
10 years
62.50
Extreme 62.5
106.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 19-08-31
Director of Finance/CFO 58 18-09-30
Chief Tech/Sci/R&D Officer - 16-08-31
Members of the board TitleAgeSince
Director/Board Member 73 09-12-15
Director/Board Member 70 14-04-30
Director/Board Member 62 20-04-27
More insiders
Date Price Change Volume
24-02-09 86.5 +0.83% 1,366,254
24-02-08 85.79 -1.83% 1,299,894
24-02-07 87.39 +0.18% 1,121,528
24-02-06 87.23 -0.19% 1,194,411
24-02-05 87.4 -0.19% 1,285,472

Real-time Euronext Paris, February 09, 2024 at 11:37 am EST

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (71.4%): prescription drugs in the areas of specialty medicine (54.7% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (45.3%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (16.8%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (11.8%). At the end of 2022, the group had 59 production sites throughout the world. Net sales are distributed geographically as follows: France (5.3%), Europe (18%), the United States (42.5%), China (7.3%), Japan (3.8%), Brazil (2.1%), Russia (1.5%) and other (19.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
86.5 EUR
Average target price
107.1 EUR
Spread / Average Target
+23.82%
Consensus
1st Jan change Capi.
-3.63% 117 B $
+26.97% 666 B $
+19.17% 536 B $
+0.01% 377 B $
+15.07% 318 B $
+12.33% 307 B $
-8.02% 207 B $
+4.05% 206 B $
-7.92% 191 B $
-4.27% 156 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock Sanofi - Euronext Paris
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer